Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial (NCT05610319)

🧪 Interventions in This Study

• Faricimab (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (46 Sites)

Showing the first 25 of 46 sites.

• Retinal Consultants Medical Group Inc. — Modesto, California
• Vitreo-Retina Medical Group — Sacramento, California
• University Retina and Macula Associates — Oak Forest, Illinois
• Eye Associates of Northeast Louisiana Dba Haik Humble Eye Center — West Monroe, Louisiana
• Mississippi Retina Associates — Jackson, Mississippi
• Austin Retina Associates — Austin, Texas
• Retina Consultants of Texas — Beaumont, Texas
• Retina & Vitreous of Texas — Bellaire, Texas
• Retina Consultants of Houston, dba Retina Consultants of Texas — Bellaire, Texas
• Valley Retina Institute — McAllen, Texas
• Retina Consultants of Houston, dba Retina Consultants of Texas — San Antonio, Texas
• Eye Clinic Albury Wodonga — Albury, New South Wales
• Nexus Eyecare Blacktown — Blacktown, New South Wales
• Eastern Suburbs Eye Specialists — Bondi Junction, New South Wales
• Retina and Eye Consultants — Hurstville, New South Wales
• Lane Cove Eye — Lane Cove, New South Wales
• South West Retina — Liverpool, New South Wales
• Marsden Eye Specialists — Parramatta, New South Wales
• Strathfield Retina Clinic — Strathfield, New South Wales
• South Eastern Sydney Health — Sydney, New South Wales
• Sydney Retina — Sydney, New South Wales
• Queensland Eye Institute — Woolloongabba, Queensland
• Adelaide Eye & Retina Centre — Adelaide, South Australia
• Hobart Eye Surgeons — Hobart, Tasmania
• Centre for Eye Research Australia — East Melbourne, Victoria

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetic Macular Edema

• Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT) — Beverly Hills, California
• 4D-150 in Patients With Diabetic Macular Edema — Hagerstown, Maryland
• Mean Visual Acuity Changes Following Five Injections of Aflibercept — Hamilton, Ontario
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) — Mesa, Arizona
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema — Phoenix, Arizona
• A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME — Mesa, Arizona

Explore by condition: All Diabetic Macular Edema clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.